NDC 60505-6262-00 - Piperacillin and Tazobactam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-6262
- Requested NDC
- 60505-6262-00
- Package NDCs from labels
- 60505-6262-0, 60505-6262-00
- Manufacturer
- Apotex Corp. | Shandong Anxin Pharmaceutical Co., Ltd.
- Effective date
- 2024-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TAZOBACTAM SODIUM - Apotex Corp. | Shandong Anxin Pharmaceutical Co., Ltd. | Apotex Corp. | Shandong Anxin Pharmaceutical Co., Ltd. | 2024-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-6262-0 | Piperacillin and Tazobactam | 180 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, POWDER, LYOPHILIZED, | 180 | 4 | |
| 60505-6262-0 | Piperacillin and Tazobactam | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-6262 | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP.] | 4 | Current NDC, 2 package rows | 20241015_c18109cf-d5db-4cc1-83da-537c8ab0e05c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-6262-0 | EA - Each | 60505-6262 | 156a19a6-4f64-4f9c-960f-1260055c2110 | 1 | 2023-10-16 |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | WG Critical Care, LLC | 17a400ae-cbaa-4d07-95f4-c6917dfc0585 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| Zosyn | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Baxter Healthcare Corporation | 8db6bd91-2106-4bfd-8cc8-38aaf1e18d17 | 2026-05-15 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| ZERBAXA | CEFTOLOZANE AND TAZOBACTAM | Merck Sharp & Dohme LLC | 70ac1d90-eff3-4f0b-9f46-5846c571b32f | 2026-05-12 | Warnings, Adverse reactions | UXA545ABTT |
| Piperacillin and Tazobactam and Sodium Chloride | PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE | B. Braun Medical Inc. | a63ca653-27d4-45fe-a744-77e0efe45220 | 2026-05-08 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Civica, Inc. | 19e89f8b-316b-4dd2-9724-bfe0faeba408 | 2025-12-12 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Civica, Inc. | 7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4 | 2025-09-08 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 668a2730-e95a-4639-a506-ae95a6502ca1 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | 39e19789-de4b-4fd1-ab1c-92f59496f496 | 2025-08-19 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | a5d8625e-e630-4076-bc55-46ebe861c6a5 | 2025-08-08 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | ONESOURCE SPECIALTY PHARMA LIMITED | 28258745-12e4-4f0f-b318-4a1a1bebc928 | 2025-07-21 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 9114cea1-3338-487e-87fa-cc3a409d501a | 2025-07-07 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | BluePoint Laboratories | 1aba753c-d0c2-4b35-917a-9143dd4be468 | 2025-06-20 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | 2c8f06a2-49b2-4169-94ef-182d13d248bf | 2025-05-21 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c5cddf50-e486-4ffb-9bc6-ed67ad6bc154 | 2025-04-14 | Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | a798faf5-cd97-4e35-a700-94c372978c46 | 2025-04-14 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | 6a894b94-171f-4217-81a2-0e84796b0b41 | 2025-04-11 | Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c8e3cc43-238d-4a23-95dc-157c85f83184 | 2025-04-10 | Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | 68d5384d-1691-4afc-8a1a-488f8e2ef2c5 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | 312447 M98T69Q7HP UXA545ABTT |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf | 2025-02-26 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | 9b682c66-61c6-4ade-baf4-9d68911a16b8 | 2024-10-30 | Warnings, Adverse reactions | M98T69Q7HP UXA545ABTT |